Online Insomnia Intervention to Reduce Alcohol Use
Testing an Online Insomnia Intervention to Reduce Alcohol Use Via Improved Sleep Among Heavy Drinkers
2 other identifiers
interventional
113
1 country
1
Brief Summary
Alcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. While research suggests that treating insomnia may effectively reduce AUD, the degree to which treating insomnia in heavy drinkers reduces alcohol consumption and prevents the onset of severe AUD is not known. This study will be the first to evaluate an Internet-based version of cognitive behavioral therapy for insomnia (CBT-I) in community-dwelling, heavy drinking adults with insomnia. Sleep Healthy Using the Internet (SHUTi), the most widely-used and well-validated version of Internet-based CBT-I will be used. The primary aim is to reduce alcohol consumption and insomnia severity in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedStudy Start
First participant enrolled
January 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2025
CompletedFebruary 5, 2026
February 1, 2026
2.5 years
November 17, 2022
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change In Alcohol Use: Daily Alcohol Diaries
Participants will report the number of drinks consumed each day and proximity of alcoholic drinks to bedtime. Summary measures will include total number of drinking days, total number of drinks, average number of drinks per drinking day, and total number of binge episodes (4/5+ drinks for women/men) over a 10-day period.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change In Sleep: Insomnia Severity Index (ISI)
The ISI uses a 7-item scale to asses insomnia impact over the previous two weeks. Items scores range from 0-28. Scores indicate moderate to severe insomnia. Moderate or marked clinical improvement is indicated by a change score of \>7 or \>8 respectively.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change In Sleep: 2) Pittsburgh Sleep Quality Index (PSQI)
The PSQI indexes one-month global sleep quality using 18 items scored on a scale from 0-21. Scores # 5 indicate poor sleep quality.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change In Sleep: 3) Daily Sleep Diaries
Sleep Onset Latency (SOL). Participants will report how long it took them to fall asleep.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change In Sleep: 4) Daily Sleep Diaries
Wake after Sleep Onset (WASO): Participants will report the number of minutes awake after falling asleep.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change in Medication Use: 5) Daily Sleep Diaries
Participants will report the amount of sleep medication used each day.
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Secondary Outcomes (2)
Change In Mood: 1) Perceived Stress Scale (PSS)
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Change In Mood: 2) Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10)
33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)
Study Arms (2)
SHUTi Intervention
EXPERIMENTALAdult heavy drinkers with insomnia
Web-Based Insomnia Education Program
ACTIVE COMPARATORAdult heavy drinkers with insomnia
Interventions
Participants will be given access to a web-based program on sleep education to read at their own pace during the 9-week intervention period. The program content overlaps with SHUTi on the following topics: insomnia symptoms, impacts, and causes, basic sleep improvement strategies, and when to see a doctor. The information is akin to that found on WebMD or National Sleep Foundation website. Unlike the SHUTi program, the information is fixed, accessible immediately (no week-to-week information "unlocking") and there are no customized bedtime or wake-time suggestions based on sleep diary data.
Sleep Healthy Using the Internet (SHUTi) is a well-validated version of e-CBT-I comprised of 6 weekly educational modules and daily sleep diaries. Participants will have 9 weeks to complete 6 once-weekly educational "cores." Cores consist of: insomnia overview, sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relapse prevention, and last approximately 45 minutes each. Participants will receive weekly objectives, as well as review and feedback on the previous core's assignments and sleep diary data, new material, assignments, and a summary. These features are supplemented with interactive features (i.e., personalized goal-setting, video vignettes). Participants receive daily emails prompting them to complete the 11-item sleep and alcohol use diary daily during the intervention.
Eligibility Criteria
You may qualify if:
- years old
- Fluency in English
- At least weekly binge drinking episodes (4/5+ drinks for women/men)\]
- Insomnia Severity Index (ISI) scores #15
You may not qualify if:
- No internet access
- Past or current substance use disorder (other than mild or moderate AUD)
- Obstructive sleep apnea
- Bipolar disorder, schizophrenia, or other psychotic spectrum disorder
- Pregnancy or nursing for women
- Any serious medical or neurological problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Of Kentucky Psychology Research Lab
Lexington, Kentucky, 40504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Weafer, PhD
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 17, 2022
First Posted
November 29, 2022
Study Start
January 24, 2023
Primary Completion
July 7, 2025
Study Completion
July 7, 2025
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share